Easterly Government Properties DEA 深 沪
已收盘 08-01 16:00:00 美东时间
21.82
-0.180
-0.82%
华盛通- 最 高22.205
- 今 开22.15
- 成交量 49.40万股
- 最 低 21.63
- 昨 收 22.00
- 总市值 9.80亿
- 52周最高 34.5375
- 市盈率 静 47.66
- 换手率 0.00%
- 52周最低 18.8805
- 委 比 -41.84%
- 总股本 4490.52万
- 历史最高 60.60
- 量 比 1.17
- 振 幅 2.61%
- 历史最低 12.3125
- 每 手 1
- 风险率 4.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Trump privately backed marijuana rescheduling since taking office: Scotts Miracle-Gro CEO
Citing his conversation with Donald Trump on cannabis reforms, Scotts Miracle-Gro (NYSE:SMG) CEO James Hagedorn said that the U.S. President, since his inauguration in January, has privately committed...
今天 00:34
Easterly Government declares $0.45 dividend
Easterly Government (NYSE:DEA) declares $0.45/share quarterly dividend, in line with previous. Forward yield 8.13% Payable Aug. 25; for shareholders of record Aug. 13; ex-div Aug. 13. See DEA Dividend...
07-31 12:41
Paramount Group Earnings Preview
Paramount Group (NYSE:PGRE) is set to give its latest quarterly earnings report...
07-30 04:02
US GoldMining Cheers New Alaska Road Plan Linking Whistler Project to Key Infrastructure
U.S. GoldMining Inc. (NASDAQ:USGO) ("U.S. GoldMining" or the "Company") strongly commends the State of Alaska's recent announcement that the Alaska Industrial Development and Export Authority ("AIDEA") has submitted a
07-28 18:08
A Look Ahead: Piedmont Office Realty's Earnings Forecast
Piedmont Office Realty (NYSE:PDM) is set to give its latest quarterly earnings ...
07-26 01:02
Tilray Brands Q4 Earnings Preview: What to expect
When Tilray Brands (NASDAQ:TLRY) reports fourth quarter earnings on Monday, Wall Street expects the firm to post EPS of -$0.03, while revenue is expected to increase 1.5% to $233.29 million during the...
07-25 22:23
U.S. Senate confirms President Trump’s DEA pick
The U.S. Senate gave the final go-ahead on Tuesday to confirm Terrance Cole, President Donald Trump’s nominee to lead the Drug Enforcement Agency (DEA). In early February, Trump nominated Cole as the ...
07-23 00:17
Chamath Palihapitiya Mocks Critics After Profiting From S&P vs Mag7 Trade: 'It's Called Leverage'
Billionaire venture capitalist Chamath Palihapitiya took to X to share his thoughts on the stock market and offer some advice to investors. What Happened: On Sunday, Palihapitiya posted about a trade idea he had shared on the All In Podcast in January.
07-21 21:08
Sarepta's Shocking Stand: Company Rejects FDA Request To Pull Gene Therapy Elevidys
FDA places clinical hold on Sarepta's LGMD gene therapy trials after three deaths and revokes platform tech designation due to safety concerns.
07-21 19:45
